Google LLC v. Sandpiper CDN, LLC

IPR2025-01010

Google LLC seeks Director Review of a PTAB decision that instituted review of its eight‑year‑old CDN patent (U.S. Pat. 10,057,322). Sandpiper CDN, LLC argues the Board ignored settled‑expectations doctrine and misapplied discretionary‑denial standards.

Jurisdiction
US PTAB
Case Number
IPR2025-01010
Filing Date
23 May 2025
Status
ok

Related Cases

patentIPR2024-00565

Juniper Networks, IncvsMonarch Networking Solutions LLC

Juniper Networks challenges the validity of Monarch Networking Solutions' '845 patent, asserting that claims related to IPv6/IPv4 transition and NAT are obvious under 35 U.S.C. § 103. The petitioner relies on combinations of prior art references (Li, Li-2, Paunikar, Wu) to demonstrate the lack of nonobviousness in networking technology.

patentIPR2025-00141

Skechers U.S.A., Inc.vsNike, Inc.

The PTAB institution of IPR2025-00141, filed by Skechers against Nike, moves forward to challenge the patent's validity on grounds of anticipation (102) and obviousness (103). The Board found that Petitioner demonstrated a reasonable likelihood of prevailing after vacating an initial discretionary denial.

patentIPR2024-00975

Innoscience America, Inc. et al.vsInfineon Technologies Austria AG

Innoscience America challenges Infineon's patent on power semiconductor packaging, asserting obviousness under 35 U.S.C. § 103. The petitioner argues that combining known device structures with established packaging techniques renders the claimed features predictable to a Person Having Ordinary Skill in the Art.

patentIPR2026-00173

Ford Motor CompanyvsAutoConnect Holdings LLC

Ford Motor Company has filed an IPR petition challenging AutoConnect’s U.S. Patent 9,173,100 covering vehicle network security. The petition argues lack of priority support and obviousness over four prior‑art references. Ford seeks institution and a finding that the claims are unpatentable.

patentPGR2025-00024

Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.

Merck Sharp & Dohme LLC successfully challenged Halozyme, Inc.'s '590 patent on grounds of enablement and obviousness. The PTAB found the claims were overly broad regarding polypeptide scope, requiring undue experimentation for a skilled artisan.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call